235 related articles for article (PubMed ID: 30599067)
41. C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively.
Xie H; Xiao Z; Huang J
J Mol Neurosci; 2016 Jul; 59(3):334-42. PubMed ID: 26614345
[TBL] [Abstract][Full Text] [Related]
42. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.
Laws SM; Eckart K; Friedrich P; Kurz A; Förstl H; Riemenschneider M
Neurobiol Aging; 2011 Mar; 32(3):541-3. PubMed ID: 19344981
[TBL] [Abstract][Full Text] [Related]
43. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
44. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
Shackleton B; Crawford F; Bachmeier C
Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
[TBL] [Abstract][Full Text] [Related]
46. Analysis of mRNA and Protein Levels of
Di Maio A; De Rosa A; Pelucchi S; Garofalo M; Marciano B; Nuzzo T; Gardoni F; Isidori AM; Di Luca M; Errico F; De Bartolomeis A; Marcello E; Usiello A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163460
[TBL] [Abstract][Full Text] [Related]
47. A Bioengineering Strategy to Control ADAM10 Activity in Living Cells.
Pastore F; Battistoni M; Sollazzo R; Renna P; Paciello F; Li Puma DD; Barone E; Dagliyan O; Ripoli C; Grassi C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674432
[TBL] [Abstract][Full Text] [Related]
48. Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells.
Wang XF; Liu DX; Liang Y; Xing LL; Zhao WH; Qin XX; Shang DS; Li B; Fang WG; Cao L; Zhao WD; Chen YH
PLoS One; 2016; 11(8):e0161093. PubMed ID: 27532339
[TBL] [Abstract][Full Text] [Related]
49. Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.
Akhter R; Shao Y; Shaw M; Formica S; Khrestian M; Leverenz JB; Bekris LM
Neurobiol Aging; 2018 Mar; 63():110-119. PubMed ID: 29253717
[TBL] [Abstract][Full Text] [Related]
50. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53-mediated trans-repression of β-secretase.
Singh AK; Pati U
Aging Cell; 2015 Aug; 14(4):595-604. PubMed ID: 25773675
[TBL] [Abstract][Full Text] [Related]
51. nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.
Amadio M; Pascale A; Wang J; Ho L; Quattrone A; Gandy S; Haroutunian V; Racchi M; Pasinetti GM
J Alzheimers Dis; 2009; 16(2):409-19. PubMed ID: 19221430
[TBL] [Abstract][Full Text] [Related]
52. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
53. microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.
Manzine PR; Pelucchi S; Horst MA; Vale FAC; Pavarini SCI; Audano M; Mitro N; Di Luca M; Marcello E; Cominetti MR
J Alzheimers Dis; 2018; 61(1):113-123. PubMed ID: 29036829
[TBL] [Abstract][Full Text] [Related]
54. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
55. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease.
Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM
BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875
[TBL] [Abstract][Full Text] [Related]
56. A Functional Polymorphism-Mediated Disruption of EGR1/ADAM10 Pathway Confers the Risk of Sepsis Progression.
Chen F; Wang Y; Zhang W; Cai Y; Zhao T; Mai H; Tao S; Wei W; Li J; Chen X; Li X; Tang P; Fan W; Yang J; Ou M; Lu F; Lai Z; Chen H; Zou T; Sun F; Shao Y; Cui L
mBio; 2019 Aug; 10(4):. PubMed ID: 31387910
[TBL] [Abstract][Full Text] [Related]
57. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation.
Zhu X; Li X; Zhu M; Xu K; Yang L; Han B; Huang R; Zhang A; Yao H
J Neuroinflammation; 2018 Aug; 15(1):221. PubMed ID: 30075790
[TBL] [Abstract][Full Text] [Related]
58. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis.
Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M
J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155
[TBL] [Abstract][Full Text] [Related]
59. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
60. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
